EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Activation of TREK ‐1 and TREK ‐2 Two‐Pore Domain Potassium Channels by the K v 4 Channel Modulator, NS5806

E L Veale iD, P M Matthews iD, A M Rush iD, E B Stevens iD, A Mathie iD

Pharmacology Research & Perspectives · 2026-06 · 14 (3)

DOI: 10.1002/prp2.70264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 14.05.2026. Verfasst von E L Veale und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medway School of Pharmacy, University of Kent and University of Greenwich, Chatham Maritime, UK. Hauptthemen laut MEDLINE: Potassium Channels, Tandem Pore Domain, Shal Potassium Channels, Phenylurea Compounds. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Royal Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

NS5806 is a diaryl‐urea small molecule developed for the treatment of pain and neurological disorders. A potent activator of K v 4.3 potassium channels, it is widely used to study K v 4 channel physiology in excitable cells, including trigeminal neurons. Surprisingly, we found that NS5806 produced a significant, robust hyperpolarization of the resting membrane potential of all trigeminal neurons tested. Given the structural similarity of NS5806 to other negatively charged activator compounds with broad potassium channel activity, we investigated whether NS5806 might also modulate the two‐pore domain potassium (K2P) TREK channels, which are abundantly expressed in sensory neurons. Here we show that NS5806 activates both TREK‐1 and TREK‐2 channels. While NS5806 is described as a K v 4‐selective activator, our data suggest that its effects on trigeminal and other neurons may arise from concurrent activation of multiple potassium channel types, including TREK‐1 and TREK‐2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Potassium Channels, Tandem Pore DomainShal Potassium ChannelsPhenylurea CompoundsAnimalsNeuronsMiceMembrane PotentialsHumansHEK293 CellsTwo-Pore ChannelsTrigeminal GanglionTetrahydronaphthalenesTetrazoles

Stichwörter der Autor:innen

KV4NS5806TREKnegatively charged activatorstrigeminal neuronstwo‐pore domain potassium channel

Substanzen

Potassium Channels, Tandem Pore Domainpotassium channel protein TREK-1Shal Potassium ChannelsPhenylurea Compounds(5,6,7,8-tetrahydronaphthalen-1-yl)-(2-(1H-tetrazol-5-yl)phenyl)amineTwo-Pore ChannelsTetrahydronaphthalenesTetrazoles

Autor:innen und Institutionen

  • Medway School of Pharmacy, University of Kent and University of Greenwich, Chatham Maritime, UK.
  • Metrion Biosciences, Cambridge, UK.
  • School of Life Sciences, University of Westminster, London, UK.

ORCID-Profile: E L Veale, P M Matthews, A M Rush, E B Stevens, A Mathie

Förderung

  • Royal Society

Zitieren

APA

Veale, E. L., Matthews, P. M., Rush, A. M., Stevens, E. B., & Mathie, A. (2026). Activation of TREK ‐1 and TREK ‐2 Two‐Pore Domain Potassium Channels by the K v 4 Channel Modulator, NS5806. Pharmacology Research & Perspectives, 14(3). https://doi.org/10.1002/prp2.70264

Vancouver

Veale EL, Matthews PM, Rush AM, Stevens EB, Mathie A. Activation of TREK ‐1 and TREK ‐2 Two‐Pore Domain Potassium Channels by the K v 4 Channel Modulator, NS5806. Pharmacology Research & Perspectives. 2026;14(3). doi:10.1002/prp2.70264

BibTeX
@article{Veale2026,
  author = {Veale, E L and Matthews, P M and Rush, A M and Stevens, E B and Mathie, A},
  title = {Activation of TREK ‐1 and TREK ‐2 Two‐Pore Domain Potassium Channels by the K v 4 Channel Modulator, NS5806},
  journal = {Pharmacology Research & Perspectives},
  year = {2026},
  volume = {14},
  number = {3},
  doi = {10.1002/prp2.70264}
}
Kostenlos starten →